Evidence map›Paper›PMID 29862240›Full record

ArticleAnnals of translational medicine2018

The practical benefit of Phadiatop test as the first-line

Guangqiao Zeng, Haisheng Hu, Peiyan Zheng, Ge Wu, Nili Wei, Xueqing Liang, Baoqing Sun, Xiaowen Zhang

Open access · hybridAbstract read
In one paragraph

Article in Annals of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Allergic rhinitis: Review of the diagnosis and management: South African Allergic Rhinitis Working Group.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Allergen sensitization pattern of allergic adults and children in southern China: a survey based on real life data.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2019
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Guangqiao ZengState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Haisheng HuState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Peiyan ZhengState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Ge WuState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Nili WeiState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Xueqing LiangState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Baoqing SunState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
Xiaowen ZhangState Key Laboratory of Respiratory Disease, Guangzhou 510120, China.
State Key Laboratory of Respiratory Disease · CNGuangzhou Medical University · CNNational Clinical Research Center for Digestive Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhadiatop test is a variant of ImmunoCAP assay that covers a mixture of common aeroallergens. Its diagnostic efficiency in Chinese population remains so far inadequate. We validated Phadiatop testing with ImmunoCAP assays in a Chinese cohort.

methodsPhadiatop test was performed for serum samples from 290 asthmatics and 92 healthy controls previously tested with "classic" ImmunoCAP for house dust mix (hx2), molds and yeasts mix (mx2), tree pollen mix (tx4) and weed mix (wx5).

resultsPhadiatop positivity was shown in 46.2% of 290 asthmatic patients. Using ImmunoCAP as the gold standard, the concordance rate was 91.7%; negative predictive value, 92.9%; and positive predictive value, 90.2%. The sensitivity of Phadiatop test was high for hx2 (98.2%), tx4 (100%) and wx5 (95.5%), but not for mx2 (78.4%). Yet the mx2 allergen-specific immunoglobulin E (sIgE) level in all missed cases was relatively low (0.35 to 0.90 kU

conclusionsOverall, Phadiatop test may efficiently detect sensitization to common aeroallergen mixes. In light of the currently rigorous administration on crude extracts for skin tests in China, using Phadiatop as the first-line test for suspected atopy can be cost-effective.

Indexed as

allergenallergen-specific immunoglobulin E (sIgE)asthmaImmunoCAPPhadiatop test

Identifiers

PMID29862240
PMCPMC5952015
OpenAlexW2799674319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.